文献速递乳腺癌放疗放疗物理与技术

无创物理等离子体预防乳腺癌放射性皮炎:患者内随机双盲安慰剂对照试验结果

Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: Results from an intrapatient-randomised double-blind placebo-controlled trial.
PubMed 文献 · Clin Transl Radiat Oncol · 2023-11-04

患者内随机双盲安慰剂对照试验纳入64例全乳照射患者,乳房内外侧半随机接受每日120秒无创物理等离子体(NIPP)或假处理。患者内两半比较无显著差异;事后与既往前瞻性标准治疗队列比较,NIPP组完成全乳照射时≥2级放射性皮炎OR=0.28(95%CI 0.11-0.76;p=0.014),色素沉着、水肿、干性及湿性脱屑、疼痛、瘙痒、灼烧感均更少。作者认为数据提示NIPP预防放射性皮炎的潜在获益,需以物理对照组随机试验确认。

要点

  • 患者内随机比较NIPP与假处理,两半乳房间无显著差异。
  • 事后与标准治疗队列比较,≥2级放射性皮炎OR=0.28(95%CI 0.11-0.76;p=0.014)。
  • NIPP耐受性良好,未观察到副作用。

核心结论

  • 患者内随机两半乳房间无差异,但与前瞻性标准治疗队列相比,急性放射性皮肤毒性总发生率和严重程度明显更低。
  • 作者认为数据提示NIPP预防放射性皮炎的潜在获益。
  • 作者提出需以物理对照组随机试验确认这些有希望的结果(DRKS00026225)。

研究设计与样本

  • 患者内随机双盲安慰剂对照试验,每例患者乳房内外侧半随机接受每日120秒NIPP或假处理。
  • 全乳照射期间全乳使用尿素乳膏标准皮肤护理。
  • 每周分别对每半乳房盲法评估急性皮肤毒性,包括临床医生CTCAE、患者报告改良RISRAS和分光光度法客观评估。
  • 另设外部对照:来自既往前瞻性试验的可比标准治疗患者队列。
  • 共纳入64例患者。

主要发现

  • 两半乳房之间无显著差异。
  • 事后与相似标准治疗对照队列比较,完成全乳照射时≥2级放射性皮炎OR=0.28(95%CI 0.11-0.76;p=0.014)。
  • 与标准治疗对照队列比较,色素沉着更少(p<0.001)、水肿更少(p=0.020)、干性脱屑更少(p<0.001)、湿性脱屑更少(p=0.017)。
  • 与标准治疗对照队列比较,疼痛、瘙痒和灼烧感均更少(每项p<0.001)。
  • NIPP耐受性极好,未观察到副作用。

局限性

  • 患者内随机两半乳房之间无显著差异。
  • 与标准治疗队列的比较为事后比较。
  • 作者提出需以物理对照组随机试验确认这些有希望的结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To investigate the effect of topical non-invasive physical plasma (NIPP), a volatile mix generated out of ambient air, on prevention of acute radiation dermatitis (RD) during and after whole-breast irradiation (WBI). MATERIALS AND METHODS: Lateral and medial breast halves were randomised within each patient to receive either 120 s of NIPP or sham treatment daily during WBI. Standard skin care with urea lotion was applied to the whole breast. Blinded acute skin toxicity was assessed weekly for each breast half separately and included clinician- (CTCAE) and patient-reported (modified RISRAS), and objective (spectrophotometry) assessments. As an additional external control, a comparable standard of care (SoC) patient collective from a previous prospective trial was used. RESULTS: Sixty-four patients were included. There were no significant differences between breast halves. Post-hoc comparison with a similar SoC control collective revealed OR = 0.28 (95% CI 0.11-0.76; p = 0.014) for grade ≥ 2 RD upon WBI completion, along with less hyperpigmentation (p < 0.001), oedema (p = 0.020), dry (p < 0.001) and moist desquamation (p = 0.017), pain, itching, and burning (p < 0.001 for each). Tolerability of NIPP was excellent and side effects were not observed. CONCLUSION: Even though there were no differences between intrapatient-randomised breast halves, the overall incidence and severity of acute radiation-induced skin toxicity were considerably lower when compared to a prospectively collected SoC cohort. Our data suggest the potential benefit of NIPP in RD prevention. A randomised trial with a physical control group is warranted to confirm these promising results (DRKS00026225).

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Dejonckheere CS, Layer JP, Nour Y, et al. Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: Results from an intrapatient-randomised double-blind placebo-controlled trial. Clin Transl Radiat Oncol. 2023. PMID: 38021092. doi:10.1016/j.ctro.2023.100699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。